Status:
COMPLETED
Health Status, Quality of Life and Function in Survivors After Radical Treatment for Prostate Cancer. Part I and IIA
Lead Sponsor:
Sykehuset Innlandet HF
Collaborating Sponsors:
Norwegian University of Science and Technology
Conditions:
Prostate Cancer
Eligibility:
MALE
Brief Summary
In this study, addressing prostate cancer survivors, i.e. men who received potentially curative (radical) treatment two to six years ago, we will investigate if older age at time of treatment is a det...
Detailed Description
Prostate cancer is the most common male cancer in Norway, with almost 5000 new cases yearly. More than12 % of men contract prostate cancer before the age of 75. As 5-year survival is high (\>95%), a s...
Eligibility Criteria
Inclusion
- Inclusion Criteria. Study group:
- Study I:
- a) men who received radical radiotherapy or robot-assisted radical prostatectomy for prostate cancer at Innlandet Hospital Trust 01.01.2014 and 31.12.2018; b) alive and living in Innlandet County; c) fluent in Norwegian (orally and in writing); provide written informed consent
- Study IIa) the subgroup of participants in Study I who were \> 70 years by the time of treatment.
- Exclusion Criteria: None
- \-
Exclusion
Key Trial Info
Start Date :
May 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 19 2021
Estimated Enrollment :
657 Patients enrolled
Trial Details
Trial ID
NCT04863352
Start Date
May 4 2021
End Date
November 19 2021
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Innlandet Hospital Trust
Brumunddal, Norway